Atlas Trials

Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica

Clinical trial NCT04492618 · COMPLETED

Trial details

NCT number
NCT04492618
Sponsor
Aaron R. Mangold
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Necrobiosis Lipoidica
Start date
2020-09-29
Primary completion
2022-03-16
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.